The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus

The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus

IntroductionAnti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) present with a complex phenotype and are associated with high mortality and multi-organ involvement. We sought to define the transcriptional landscape and molecular endotypes of AAVs and compare it to systemic lup...

Full description

Bibliographic Details
Main Authors:	Aggelos Banos, Konstantinos Thomas, Panagiotis Garantziotis, Anastasia Filia, Nikolaos Malissovas, Antigone Pieta, Dimitrios Nikolakis, Alexandros G. Panagiotopoulos, Aglaia Chalkia, Dimitrios Petras, George Bertsias, Dimitrios T. Boumpas, Dimitrios Vassilopoulos
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Immunology
Subjects:	autoimmune diseases vasculitis lupus (SLE) transcriptomics (RNA-seq) endotypes of disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1072598/full

Similar Items

Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs
by: Panagiotis Garantziotis, et al.
Published: (2022-05-01)

Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy
by: Dimitrios Nikolakis, et al.
Published: (2023-04-01)

Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients
by: Konstantinos Thomas, et al.
Published: (2021-03-01)

Single-cell transcriptomic analysis of hematopoietic progenitor cells from patients with systemic lupus erythematosus reveals interferon-inducible reprogramming in early progenitors
by: Anastasia Filia, et al.
Published: (2024-05-01)

Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study
by: Aglaia Chalkia, et al.
Published: (2020-01-01)

Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the “Attikon” Lupus Cohort
by: Dionysis Nikolopoulos, et al.
Published: (2022-05-01)

16 Management of neuropsychiatric SLE
by: Dimitrios Boumpas
Published: (2022-04-01)

13 All lupus nephritis patients should be initially managed with established standard therapies alone
by: Dimitrios Boumpas
Published: (2021-04-01)

Phenotypes and Endotypes in Sarcoidosis: Unraveling Prognosis and Disease Course
by: Ilias C. Papanikolaou, et al.
Published: (2025-01-01)

A network-based approach reveals long non-coding RNAs associated with disease activity in lupus nephritis: key pathways for flare and potential biomarkers to be used as liquid biopsies
by: George Sentis, et al.
Published: (2023-07-01)

Distal renal tubular acidosis and nephrocalcinosis as initial manifestation of primary sjögren's syndrome
by: Aglaia Chalkia, et al.
Published: (2021-01-01)

P97 LNMap: a curated computational resource of molecular pathways in lupus nephritis
by: Dimitrios T Boumpas, et al.
Published: (2024-03-01)

P92 Quantifying the unmet need in lupus nephritis: EULAR/ERA- EDTA treatment targets, flares, and treatment modifications in the first year in a multicenter observational study
by: Maria Tektonidou, et al.
Published: (2024-03-01)

Debilitating Chronic Diarrhea Caused by Generalized Gastrointestinal Cytomegalovirus Infection in an Immunocompetent Adult
by: Emmanouil Telakis, et al.
Published: (2014-01-01)

P100 Efficacy of anifrolumab in multi-refractory skin manifestations of systemic lupus erythematosus: case series
by: George Bertsias, et al.
Published: (2024-03-01)

Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting
by: Eirini Maria Stergioti, et al.
Published: (2022-11-01)

Combined – whole blood and skin fibroblasts- transcriptomic analysis in Psoriatic Arthritis reveals molecular signatures of activity, resistance and early response to treatment
by: Alexandros Grivas, et al.
Published: (2022-09-01)

Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus.
by: Magdalene Nakou, et al.
Published: (2010-10-01)

Correction: Gene Network Analysis of Bone Marrow Mononuclear Cells Reveals Activation of Multiple Kinase Pathways in Human Systemic Lupus Erythematosus.
by: Magdalene Nakou, et al.
Published: (2013-01-01)

P75 Molecular exploration of systemic lupus erythematosus (SLE) sexual dimorphism uncovers a crucial role of SMC1A in transcriptional regulation of inflammation
by: Prodromos Sidiropoulos, et al.
Published: (2024-03-01)

Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis
by: Kalliopi Klavdianou, et al.
Published: (2020-06-01)

O13 Innate immunity transcriptional profiles as potential predictive biomarkers for treatment response in systemic lupus erythematosus: Insights from a longitudinal study
by: Dimitrios T Boumpas, et al.
Published: (2024-03-01)

Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations
by: Dimitrios T Boumpas, et al.
Published: (2020-09-01)

Patrolling human SLE haematopoietic progenitors demonstrate enhanced extramedullary colonisation; implications for peripheral tissue injury
by: Ioannis Kokkinopoulos, et al.
Published: (2021-08-01)

Fibrillary Glomerulonephritis with Atypical Immunoglobulin M Deposits and Hypocomplementemia Revealed Human Immunodeficiency Virus Infection
by: Aglaia Chalkia, et al.
Published: (2021-01-01)

Mesenchymal Stem Cell and Hematopoietic Stem and Progenitor Cell Co-Culture in a Bone-Marrow-on-a-Chip Device toward the Generation and Maintenance of the Hematopoietic Niche
by: Dionysia Kefallinou, et al.
Published: (2024-07-01)

Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent
by: Alessia Alunno, et al.
Published: (2019-08-01)

Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational study
by: Dimitrios T Boumpas, et al.
Published: (2024-09-01)

P70 Exposure to DORIS ≥50% of time and to LLDAS ≥60% of observation time exhibit the best combination of feasibility and protection against adverse outcomes in moderate-to-severe SLE
by: Alessandra Bortoluzzi, et al.
Published: (2024-03-01)

Anxiety and depression severity in neuropsychiatric SLE are associated with perfusion and functional connectivity changes of the frontolimbic neural circuit: a resting-state f(unctional) MRI study
by: Efrosini Papadaki, et al.
Published: (2021-05-01)

Infections in psoriatic arthritis: association with treatment
by: Athanasios Vassilopoulos, et al.
Published: (2024-10-01)

Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease
by: Dimitrios T Boumpas, et al.
Published: (2020-11-01)

Altered hippocampal connectivity dynamics predicts memory performance in neuropsychiatric lupus: a resting-state fMRI study using cross-recurrence quantification analysis
by: Dimitrios T Boumpas, et al.
Published: (2023-11-01)

Fabrication of a 3D microfluidic cell culture device for bone marrow-on-a-chip
by: Dionysia Kefallinou, et al.
Published: (2020-11-01)

Real world, big data cost of pharmaceutical treatment for rheumatoid arthritis in Greece.
by: Kyriakos Souliotis, et al.
Published: (2019-01-01)

Analysis of transcriptomic features reveals molecular endotypes of SLE with clinical implications
by: Erika L. Hubbard, et al.
Published: (2023-10-01)

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study
by: Myrto Nikoloudaki, et al.
Published: (2023-01-01)

Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group
by: Irini Genitsaridi, et al.
Published: (2020-09-01)

IFNα Impairs Autophagic Degradation of mtDNA Promoting Autoreactivity of SLE Monocytes in a STING-Dependent Fashion
by: Katerina Gkirtzimanaki, et al.
Published: (2018-10-01)

Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
by: Christos Koutsianas, et al.
Published: (2020-03-01)